IBio - Stock Price History | IBIO

Historical daily share price chart and data for IBio since 2021 adjusted for splits. The latest closing stock price for IBio as of September 27, 2021 is 1.14.
  • The all-time high IBio stock closing price was 58.50 on January 18, 2011.
  • The IBio 52-week high stock price is 2.83, which is 148.2% above the current share price.
  • The IBio 52-week low stock price is 1.03, which is 9.6% below the current share price.
  • The average IBio stock price for the last 52 weeks is 1.52.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
IBio Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 1.6599 0.2960 6.4100 0.2230 1.0500 321.69%
2019 0.6518 0.7813 1.0000 0.1090 0.2490 -66.95%
2018 1.2934 1.8500 2.9500 0.5700 0.7534 -57.46%
2017 3.4653 3.7010 5.2000 1.4100 1.7710 -55.16%
2016 5.8025 5.6000 7.3970 3.5000 3.9500 -29.46%
2015 7.4691 6.4900 11.3000 4.2000 5.6000 -18.25%
2014 6.3257 3.5000 32.1000 3.4900 6.8500 104.48%
2013 4.8599 6.8490 8.6500 2.9300 3.3500 -45.97%
2012 10.1521 8.9960 18.9000 6.2000 6.2000 -25.30%
2011 26.4825 30.9000 58.5000 7.6000 8.3000 -73.73%
2010 16.2736 9.0000 33.5000 5.7000 31.6000 251.11%
2009 6.1204 1.1500 14.4000 1.1500 9.0000 757.14%
2008 8.1948 9.5000 20.0000 1.0500 1.0500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.248B $0.002B
Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture of proteins applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus and veterinary influenza applications. IBio, Inc. is headquartered in Newark, Delaware.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29